The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Abeona Therapeutics, Inc. | COM | 00289Y107 | 117 | 18,334 | SH | SOLE | 18,334 | 0 | 0 | ||
| Acceleron Pharma Inc. | COM | 00434H108 | 604 | 19,886 | SH | SOLE | 19,886 | 0 | 0 | ||
| Achaogen, Inc. | COM | 004449104 | 27,163 | 1,250,000 | SH | SOLE | 1,250,000 | 0 | 0 | ||
| Aerie Pharmaceuticals, Inc. | COM | 00771V108 | 102,498 | 1,950,477 | SH | SOLE | 1,950,477 | 0 | 0 | ||
| Aimmune Therapeutics, Inc. | COM | 00900T107 | 18,751 | 912,001 | SH | SOLE | 912,001 | 0 | 0 | ||
| Alder BioPharmaceuticals, Inc. | COM | 014339105 | 24,929 | 2,177,203 | SH | SOLE | 2,177,203 | 0 | 0 | ||
| Ardelyx, Inc. | COM | 039697107 | 191 | 37,500 | SH | SOLE | 37,500 | 0 | 0 | ||
| argenx SE | SPONSORED ADR | 04016X101 | 3,744 | 176,500 | SH | SOLE | 176,500 | 0 | 0 | ||
| Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 622 | 22,400 | SH | SOLE | 22,400 | 0 | 0 | ||
| Bellicum Pharmaceuticals, Inc. | COM | 079481107 | 5,288 | 452,727 | SH | SOLE | 452,727 | 0 | 0 | ||
| Biohaven Pharmaceutical Holding Company Ltd. | COM | G11196105 | 750 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
| Blueprint Medicines Corporation | COM | 09627Y109 | 23,308 | 460,000 | SH | SOLE | 460,000 | 0 | 0 | ||
| Dermira, Inc. | COM | 24983L104 | 5,135 | 176,211 | SH | SOLE | 176,211 | 0 | 0 | ||
| Epizyme, Inc. | COM | 29428V104 | 12,070 | 799,363 | SH | SOLE | 799,363 | 0 | 0 | ||
| Fibrogen, Inc. | COM | 31572Q808 | 8,075 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| Immunomedics, Inc. | COM | 452907108 | 17,138 | 1,940,850 | SH | SOLE | 1,940,850 | 0 | 0 | ||
| Infinity Pharmaceuticals, Inc. | COM | 45665G303 | 1,160 | 738,896 | SH | SOLE | 738,896 | 0 | 0 | ||
| Loxo Oncology, Inc. | COM | 548862101 | 9,021 | 112,500 | SH | SOLE | 112,500 | 0 | 0 | ||
| NanoString Technologies, Inc. | COM | 63009R109 | 2,955 | 178,681 | SH | SOLE | 178,681 | 0 | 0 | ||
| Orexigen Therapeutics, Inc. | COM | 686164302 | 1,104 | 380,530 | SH | SOLE | 380,530 | 0 | 0 | ||
| Pacific Biosciences of California, Inc. | COM | 69404D108 | 4,450 | 1,250,000 | SH | SOLE | 1,250,000 | 0 | 0 | ||
| Sangamo Therapeutics Inc. | COM | 800677106 | 1,355 | 154,000 | SH | SOLE | 154,000 | 0 | 0 | ||
| Tocagen, Inc. | COM | 888846102 | 9,059 | 753,000 | SH | SOLE | 753,000 | 0 | 0 | ||
| Verona Pharma Plc | SPONSORED ADS | 925050106 | 7,152 | 613,601 | SH | SOLE | 613,601 | 0 | 0 | ||
| WAVE Life Sciences Ltd. | SHS | Y95308105 | 18,676 | 1,004,100 | SH | SOLE | 1,004,100 | 0 | 0 | ||
| Zafgen, Inc. | COM | 98885E103 | 822 | 234,092 | SH | SOLE | 234,092 | 0 | 0 | ||